Full-Time

Associate Director

Medical Writing

Confirmed live in the last 24 hours

Corcept Therapeutics

Corcept Therapeutics

201-500 employees

Develops cortisol modulators for medical conditions

Biotechnology
Healthcare

Compensation Overview

$159k - $212.9kAnnually

Senior, Expert

San Carlos, CA, USA

Category
Technical Writing
Content & Writing
Medical, Clinical & Veterinary
Requirements
  • Excellent writing skills coupled with good understanding of the drug development process and relevant regulatory guidelines
  • Ability to write and edit complex material to ensure accuracy, clarity, consistency, and effectiveness
  • Successful track record of working on complex clinical/regulatory writing projects across multiple therapeutic areas
  • Excellent attention to detail, multitasking, prioritization, and flexibility
  • Excellent communication skills with proven ability to interact in a cross-functional environment
  • Understanding of the drug-development process, including research and development processes and objectives and the required documents
  • Familiarity with US and European regulatory requirements and guidelines for documents; general knowledge of electronic Common Technical Document (e-CTD) requirements with respect to structure, format, and content
  • Ability to analyze critically and synthesize complex scientific information from a range of scientific disciplines and clinical therapeutic areas
  • Proficiency in use of MS Office applications (Word, Outlook, Excel, Powerpoint), Adobe Acrobat, electronic document management systems (eg, Veeva Vault, Box, SharePoint), and templates (eg, StartingPoint)
  • Comfortable in a fast-paced small company environment with minimal direction and able to adjust workload based on changing priorities
  • Demonstrated initiative and the ability to manage a variety of projects simultaneously with minimal supervision
  • BA/BS degree in a scientific field required; advanced scientific degree (PhD, PharmD, or MS) preferred
  • 8+ years of regulatory medical writing experience in the pharmaceutical industry (or an organization serving them), including experience writing clinical study protocols, clinical study reports, investigator’s brochures, clinical sections of Investigational New Drug (IND) submissions and New Drug Applications (NDAs); and understanding of the content of higher-level summary documents
Responsibilities
  • Author, co-author, critically edit, and format clinical/regulatory documents, including New Drug Applications (NDAs), protocols/protocol amendments, clinical study reports (CSRs), Investigator’s Brochures, administrative letters, and other regulatory submissions as needed
  • Interact with document authors, contributors, and reviewers (including members of Biometrics, Clinical Operations, Clinical Development, Project Management, CMC, Drug Safety, and Regulatory Affairs) to acquire necessary input into documents
  • Develop and manage medical writing timelines for assigned documents to ensure on-time deliverables that meet business needs
  • Facilitate comment resolution and adjudication with authors, reviewers, and project teams
  • Oversee vendors and contractors
  • May include management of in-house medical writing staff (based on experience and team need)
  • Serve as the functional area representative on project teams and advise such teams on content, format, and style requirements for documents
  • Lead the development/refinement of medical writing processes, SOPs, work instructions, templates, style and content guides, and document quality control to ensure efficient preparation of high-quality medical writing deliverables
  • Interview, mentor, and assist in the integration of medical writing staff as needed
  • Maintain subject area expertise related to the company’s investigational products, disease indications, and regulatory and publication guidelines

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing stress, metabolism, and immune functions. Their main product, Korlym, is the first FDA-approved treatment for Cushing's syndrome, a condition caused by excessive cortisol. The company has discovered over 1,000 selective cortisol modulators and aims to expand its offerings with new treatments in development. Unlike many competitors, Corcept emphasizes both research and patient education, providing resources to healthcare professionals and patients to improve understanding and care for cortisol-related conditions. The goal of Corcept is to lead in cortisol modulation therapies and enhance patient outcomes for those suffering from related disorders.

Company Stage

IPO

Total Funding

$39.7M

Headquarters

Menlo Park, California

Founded

1998

Growth & Insights
Headcount

6 month growth

23%

1 year growth

31%

2 year growth

49%
Simplify Jobs

Simplify's Take

What believers are saying

  • Growing interest in cortisol therapies due to stress-related health awareness boosts market potential.
  • Advancements in personalized medicine could enhance the effectiveness of Corcept's treatments.
  • Increased investments in biopharmaceuticals focusing on niche markets support Corcept's growth.

What critics are saying

  • Teva's antitrust lawsuit could lead to legal expenses and market share loss.
  • Strategic shift towards oncology may divert resources from core cortisol focus.
  • Recent stock offering may dilute shareholder value, indicating potential financial challenges.

What makes Corcept Therapeutics unique

  • Corcept specializes in cortisol modulation, a niche market with few competitors.
  • Korlym is the first FDA-approved treatment for hypercortisolism in Cushing's syndrome.
  • Corcept has discovered over 1,000 selective cortisol modulators, showcasing strong R&D capabilities.

Help us improve and share your feedback! Did you find this helpful?